Industry Research Reports

Home > Reports > Chemical & Material > Global and United States Myostatin Market Report & Forecast 2024-2030

Global and United States Myostatin Market Report & Forecast 2024-2030

Industry: Chemical & Material

Published Date: 2024-08-24

Pages: 124 Pages

Report ld: 3296833

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.

The global Myostatin revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In United States the Myostatin revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Myostatin market, also covers the segmentation data of other regions in regional level and county level.

The global key players of Myostatin include Bio-Techne, Prospec, NeoScientific, FUJIFILM Irvine Scientific, R&D Systems, Beta Lifescience, ACROBiosystems, Biohaven, RayBiotech, Sino Biological, etc. The global five biggest players hold a share of % in 2023.

Myostatin market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Myostatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Myostatin market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

MARKET SEGMENTATION

By Company

Bio-Techne
Prospec
NeoScientific
FUJIFILM Irvine Scientific
R&D Systems
Beta Lifescience
ACROBiosystems
Biohaven
RayBiotech
Sino Biological
BioVendor
Cell Guidance Systems
MerckMillipore

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Active
Inactive

Segment by Application

Gene Therapy
Basic Scientific Research
Treating Muscular Dystrophy
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces Myostatin definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Myostatin companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Myostatin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Myostatin sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Myostatin Product Introduction

1.2 Global Myostatin Outlook 2019 VS 2023 VS 2030

1.2.1 Global Myostatin Sales in US$ Million for the Year 2019-2030

1.2.2 Global Myostatin Sales in Volume for the Year 2019-2030

1.3 United States Myostatin Outlook 2019 VS 2023 VS 2030

1.3.1 United States Myostatin Sales in US$ Million for the Year 2019-2030

1.3.2 United States Myostatin Sales in Volume for the Year 2019-2030

1.4 Myostatin Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.4.1 The Market Share of United States Myostatin in Global, 2019 VS 2023 VS 2030

1.4.2 The Growth Rate of Myostatin Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.5 Myostatin Market Dynamics

1.5.1 Myostatin Industry Trends

1.5.2 Myostatin Market Drivers

1.5.3 Myostatin Market Challenges

1.5.4 Myostatin Market Restraints

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Myostatin by Type

2.1 Myostatin Market by Type

2.1.1 Active

2.1.2 Inactive

2.2 Global Myostatin Market Size by Type

2.2.1 Global Myostatin Sales in Value, by Type (2019, 2023 & 2030)

2.2.2 Global Myostatin Sales in Volume, by Type (2019, 2023 & 2030)

2.2.3 Global Myostatin Average Selling Price (ASP) by Type (2019, 2023 & 2030)

2.3 United States Myostatin Market Size by Type

2.3.1 United States Myostatin Sales in Value, by Type (2019, 2023 & 2030)

2.3.2 United States Myostatin Sales in Volume, by Type (2019, 2023 & 2030)

2.3.3 United States Myostatin Average Selling Price (ASP) by Type (2019, 2023 & 2030)

3 Myostatin by Application

3.1 Myostatin Market by Application

3.1.1 Gene Therapy

3.1.2 Basic Scientific Research

3.1.3 Treating Muscular Dystrophy

3.1.4 Others

3.2 Global Myostatin Market Size by Application

3.2.1 Global Myostatin Sales in Value, by Application (2019, 2023 & 2030)

3.2.2 Global Myostatin Sales in Volume, by Application (2019, 2023 & 2030)

3.2.3 Global Myostatin Average Selling Price (ASP) by Application (2019, 2023 & 2030)

3.3 United States Myostatin Market Size by Application

3.3.1 United States Myostatin Sales in Value, by Application (2019, 2023 & 2030)

3.3.2 United States Myostatin Sales in Volume, by Application (2019, 2023 & 2030)

3.3.3 United States Myostatin Average Selling Price (ASP) by Application (2019, 2023 & 2030)

4 Global Myostatin Competitor Landscape by Company

4.1 Global Myostatin Market Size by Company

4.1.1 Global Key Manufacturers of Myostatin, Ranked by Revenue (2023)

4.1.2 Global Myostatin Revenue by Manufacturer (2019-2024)

4.1.3 Global Myostatin Sales by Manufacturer (2019-2024)

4.1.4 Global Myostatin Price by Manufacturer (2019-2024)

4.2 Global Myostatin Concentration Ratio (CR)

4.2.1 Myostatin Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Myostatin in 2023

4.2.3 Global Myostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Myostatin, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Myostatin, Product Offered and Application

4.5 Global Key Manufacturers of Myostatin, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 United States Myostatin Market Size by Company

4.7.1 Key Players of Myostatin in United States, Ranked by Revenue (2023)

4.7.2 United States Myostatin Revenue by Players (2019-2024)

4.7.3 United States Myostatin Sales by Players (2019-2024)

5 Global Myostatin Market Size by Region

5.1 Global Myostatin Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global Myostatin Market Size in Volume by Region (2019-2030)

5.2.1 Global Myostatin Sales in Volume by Region: 2019-2024

5.2.2 Global Myostatin Sales in Volume Forecast by Region (2025-2030)

5.3 Global Myostatin Market Size in Value by Region (2019-2030)

5.3.1 Global Myostatin Sales in Value by Region: 2019-2024

5.3.2 Global Myostatin Sales in Value by Region: 2025-2030

6 Americas

6.1 Americas Myostatin Market Size YoY Growth 2019-2030

6.2 Americas Myostatin Sales in Volume, by Type (2019, 2023 & 2030)

6.3 Americas Myostatin Sales in Volume, by Application (2019, 2023 & 2030)

6.4 Americas Myostatin Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 Americas Myostatin Sales in Value by Country (2019, 2023 & 2030)

6.4.2 Americas Myostatin Sales in Volume by Country (2019, 2023 & 2030)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Myostatin Market Size YoY Growth 2019-2030

7.2 EMEA Myostatin Sales in Volume, by Type (2019, 2023 & 2030)

7.3 EMEA Myostatin Sales in Volume, by Application (2019, 2023 & 2030)

7.4 EMEA Myostatin Market Facts & Figures by Country (2019, 2023 & 2030)

7.4.1 EMEA Myostatin Sales in Value by Country (2019, 2023 & 2030)

7.4.2 EMEA Myostatin Sales in Volume by Country (2019, 2023 & 2030)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Myostatin Market Size YoY Growth 2019-2030

8.2 China Myostatin Sales in Volume, by Type (2019, 2023 & 2030)

8.3 China Myostatin Sales in Volume, by Application (2019, 2023 & 2030)

9 APAC

9.1 APAC Myostatin Market Size YoY Growth 2019-2030

9.2 APAC Myostatin Sales in Volume, by Type (2019, 2023 & 2030)

9.3 APAC Myostatin Sales in Volume, by Application (2019, 2023 & 2030)

9.4 APAC Myostatin Market Facts & Figures by Country (2019, 2023 & 2030)

9.4.1 APAC Myostatin Sales in Value by Country (2019, 2023 & 2030)

9.4.2 APAC Myostatin Sales in Volume by Country (2019, 2023 & 2030)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Bio-Techne

10.1.1 Bio-Techne Company Information

10.1.2 Bio-Techne Description and Business Overview

10.1.3 Bio-Techne Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.1.4 Bio-Techne Myostatin Products Offered

10.1.5 Bio-Techne Recent Development

10.2 Prospec

10.2.1 Prospec Company Information

10.2.2 Prospec Description and Business Overview

10.2.3 Prospec Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.2.4 Prospec Myostatin Products Offered

10.2.5 Prospec Recent Development

10.3 NeoScientific

10.3.1 NeoScientific Company Information

10.3.2 NeoScientific Description and Business Overview

10.3.3 NeoScientific Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.3.4 NeoScientific Myostatin Products Offered

10.3.5 NeoScientific Recent Development

10.4 FUJIFILM Irvine Scientific

10.4.1 FUJIFILM Irvine Scientific Company Information

10.4.2 FUJIFILM Irvine Scientific Description and Business Overview

10.4.3 FUJIFILM Irvine Scientific Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.4.4 FUJIFILM Irvine Scientific Myostatin Products Offered

10.4.5 FUJIFILM Irvine Scientific Recent Development

10.5 R&D Systems

10.5.1 R&D Systems Company Information

10.5.2 R&D Systems Description and Business Overview

10.5.3 R&D Systems Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.5.4 R&D Systems Myostatin Products Offered

10.5.5 R&D Systems Recent Development

10.6 Beta Lifescience

10.6.1 Beta Lifescience Company Information

10.6.2 Beta Lifescience Description and Business Overview

10.6.3 Beta Lifescience Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.6.4 Beta Lifescience Myostatin Products Offered

10.6.5 Beta Lifescience Recent Development

10.7 ACROBiosystems

10.7.1 ACROBiosystems Company Information

10.7.2 ACROBiosystems Description and Business Overview

10.7.3 ACROBiosystems Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.7.4 ACROBiosystems Myostatin Products Offered

10.7.5 ACROBiosystems Recent Development

10.8 Biohaven

10.8.1 Biohaven Company Information

10.8.2 Biohaven Description and Business Overview

10.8.3 Biohaven Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.8.4 Biohaven Myostatin Products Offered

10.8.5 Biohaven Recent Development

10.9 RayBiotech

10.9.1 RayBiotech Company Information

10.9.2 RayBiotech Description and Business Overview

10.9.3 RayBiotech Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.9.4 RayBiotech Myostatin Products Offered

10.9.5 RayBiotech Recent Development

10.10 Sino Biological

10.10.1 Sino Biological Company Information

10.10.2 Sino Biological Description and Business Overview

10.10.3 Sino Biological Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.10.4 Sino Biological Myostatin Products Offered

10.10.5 Sino Biological Recent Development

10.11 BioVendor

10.11.1 BioVendor Company Information

10.11.2 BioVendor Description and Business Overview

10.11.3 BioVendor Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.11.4 BioVendor Myostatin Products Offered

10.11.5 BioVendor Recent Development

10.12 Cell Guidance Systems

10.12.1 Cell Guidance Systems Company Information

10.12.2 Cell Guidance Systems Description and Business Overview

10.12.3 Cell Guidance Systems Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.12.4 Cell Guidance Systems Myostatin Products Offered

10.12.5 Cell Guidance Systems Recent Development

10.13 MerckMillipore

10.13.1 MerckMillipore Company Information

10.13.2 MerckMillipore Description and Business Overview

10.13.3 MerckMillipore Myostatin Sales, Revenue and Gross Margin (2019-2024)

10.13.4 MerckMillipore Myostatin Products Offered

10.13.5 MerckMillipore Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Myostatin Industry Chain Analysis

11.2 Myostatin Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Myostatin Production Mode & Process

11.4 Myostatin Sales and Marketing

11.4.1 Myostatin Sales Channels

11.4.2 Myostatin Distributors

11.5 Myostatin Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Myostatin CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030

Table 2. Myostatin Market Trends

Table 3. Myostatin Market Drivers

Table 4. Myostatin Market Challenges

Table 5. Myostatin Market Restraints

Table 6. Global Myostatin Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. United States Myostatin Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Myostatin Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. United States Myostatin Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Manufacturers of Myostatin, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global Myostatin Revenue by Manufacturer, (US$ Million) & (2019-2024)

Table 12. Global Myostatin Revenue Share by Manufacturer, 2019-2024

Table 13. Global Myostatin Sales by Manufacturer, (kg), 2019-2024

Table 14. Global Myostatin Sales Share by Manufacturer, 2019-2024

Table 15. Global Myostatin Price by Manufacturer (2019-2024) & (US$/kg)

Table 16. Global Myostatin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Myostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myostatin as of 2023)

Table 18. Global Key Manufacturers of Myostatin, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Myostatin, Product Offered and Application

Table 20. Global Key Manufacturers of Myostatin, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Myostatin in United States, Ranked by Revenue (2023) & (US$ million)

Table 23. United States Myostatin Revenue by Players, (US$ Million) & (2019-2024)

Table 24. United States Myostatin Revenue Share by Players, (2019-2024)

Table 25. United States Myostatin Sales by Players, (kg) & (2019-2024)

Table 26. United States Myostatin Sales Share by Players, (2019-2024)

Table 27. Global Myostatin Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 28. Global Myostatin Sales in Volume by Region (2019-2024) & (kg)

Table 29. Global Myostatin Sales in Volume Forecast by Region (2025-2030) & (kg)

Table 30. Global Myostatin Sales in Value by Region (2019-2024) & (US$ Million)

Table 31. Global Myostatin Sales in Value Forecast by Region (2025-2030) & (US$ Million)

Table 32. Americas Myostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. Americas Myostatin Sales in Value by Country (2019-2024) & (US$ Million)

Table 34. Americas Myostatin Sales in Value by Country (2025-2030) & (US$ Million)

Table 35. Americas Myostatin Sales in Volume by Country (2019-2024) & (kg)

Table 36. Americas Myostatin Sales in Volume by Country (2025-2030) & (kg)

Table 37. EMEA Myostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. EMEA Myostatin Sales in Value by Country (2019-2024) & (US$ Million)

Table 39. EMEA Myostatin Sales in Value by Country (2025-2030) & (US$ Million)

Table 40. EMEA Myostatin Sales in Volume by Country (2019-2024) & (kg)

Table 41. EMEA Myostatin Sales in Volume by Country (2025-2030) & (kg)

Table 42. APAC Myostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. APAC Myostatin Sales in Value by Country (2019-2024) & (US$ Million)

Table 44. APAC Myostatin Sales in Value by Country (2025-2030) & (US$ Million)

Table 45. APAC Myostatin Sales in Volume by Country (2019-2024) & (kg)

Table 46. APAC Myostatin Sales in Volume by Country (2025-2030) & (kg)

Table 47. Bio-Techne Company Information

Table 48. Bio-Techne Description and Business Overview

Table 49. Bio-Techne Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 50. Bio-Techne Myostatin Product

Table 51. Bio-Techne Recent Development

Table 52. Prospec Company Information

Table 53. Prospec Description and Business Overview

Table 54. Prospec Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 55. Prospec Myostatin Product

Table 56. Prospec Recent Development

Table 57. NeoScientific Company Information

Table 58. NeoScientific Description and Business Overview

Table 59. NeoScientific Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 60. NeoScientific Myostatin Product

Table 61. NeoScientific Recent Development

Table 62. FUJIFILM Irvine Scientific Company Information

Table 63. FUJIFILM Irvine Scientific Description and Business Overview

Table 64. FUJIFILM Irvine Scientific Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 65. FUJIFILM Irvine Scientific Myostatin Product

Table 66. FUJIFILM Irvine Scientific Recent Development

Table 67. R&D Systems Company Information

Table 68. R&D Systems Description and Business Overview

Table 69. R&D Systems Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 70. R&D Systems Myostatin Product

Table 71. R&D Systems Recent Development

Table 72. Beta Lifescience Company Information

Table 73. Beta Lifescience Description and Business Overview

Table 74. Beta Lifescience Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 75. Beta Lifescience Myostatin Product

Table 76. Beta Lifescience Recent Development

Table 77. ACROBiosystems Company Information

Table 78. ACROBiosystems Description and Business Overview

Table 79. ACROBiosystems Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 80. ACROBiosystems Myostatin Product

Table 81. ACROBiosystems Recent Development

Table 82. Biohaven Company Information

Table 83. Biohaven Description and Business Overview

Table 84. Biohaven Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 85. Biohaven Myostatin Product

Table 86. Biohaven Recent Development

Table 87. RayBiotech Company Information

Table 88. RayBiotech Description and Business Overview

Table 89. RayBiotech Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 90. RayBiotech Myostatin Product

Table 91. RayBiotech Recent Development

Table 92. Sino Biological Company Information

Table 93. Sino Biological Description and Business Overview

Table 94. Sino Biological Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 95. Sino Biological Myostatin Product

Table 96. Sino Biological Recent Development

Table 97. BioVendor Company Information

Table 98. BioVendor Description and Business Overview

Table 99. BioVendor Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 100. BioVendor Myostatin Product

Table 101. BioVendor Recent Development

Table 102. Cell Guidance Systems Company Information

Table 103. Cell Guidance Systems Description and Business Overview

Table 104. Cell Guidance Systems Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 105. Cell Guidance Systems Myostatin Product

Table 106. Cell Guidance Systems Recent Development

Table 107. MerckMillipore Company Information

Table 108. MerckMillipore Description and Business Overview

Table 109. MerckMillipore Myostatin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 110. MerckMillipore Myostatin Product

Table 111. MerckMillipore Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Myostatin Distributors List

Table 115. Myostatin Customers List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Myostatin Product Picture

Figure 2. Global Myostatin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global Myostatin Market Size 2019-2030 (US$ Million)

Figure 4. Global Myostatin Sales 2019-2030 (kg)

Figure 5. United States Myostatin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 6. United States Myostatin Market Size 2019-2030 (US$ Million)

Figure 7. United States Myostatin Sales 2019-2030 (kg)

Figure 8. United States Myostatin Market Share in Global, in Value (US$ Million) 2019-2030

Figure 9. United States Myostatin Market Share in Global, in Volume (kg) 2019-2030

Figure 10. Myostatin Report Years Considered

Figure 11. Product Picture of Active

Figure 12. Product Picture of Inactive

Figure 13. Global Myostatin Market Share by Type in 2023 & 2030

Figure 14. Global Myostatin Sales in Value by Type (2019-2030) & (US$ Million)

Figure 15. Global Myostatin Sales Market Share in Value by Type (2019-2030)

Figure 16. Global Myostatin Sales by Type (2019-2030) & (kg)

Figure 17. Global Myostatin Sales Market Share in Volume by Type (2019-2030)

Figure 18. Global Myostatin Price by Type (2019-2030) & (US$/kg)

Figure 19. United States Myostatin Market Share by Type in 2023 & 2030

Figure 20. United States Myostatin Sales in Value by Type (2019-2030) & (US$ Million)

Figure 21. United States Myostatin Sales Market Share in Value by Type (2019-2030)

Figure 22. United States Myostatin Sales by Type (2019-2030) & (kg)

Figure 23. United States Myostatin Sales Market Share in Volume by Type (2019-2030)

Figure 24. United States Myostatin Price by Type (2019-2030) & (US$/kg)

Figure 25. Product Picture of Gene Therapy

Figure 26. Product Picture of Basic Scientific Research

Figure 27. Product Picture of Treating Muscular Dystrophy

Figure 28. Product Picture of Others

Figure 29. Global Myostatin Market Share by Application in 2023 & 2030

Figure 30. Global Myostatin Sales in Value by Application (2019-2030) & (US$ Million)

Figure 31. Global Myostatin Sales Market Share in Value by Application (2019-2030)

Figure 32. Global Myostatin Sales by Application (2019-2030) & (kg)

Figure 33. Global Myostatin Sales Market Share in Volume by Application (2019-2030)

Figure 34. Global Myostatin Price by Application (2019-2030) & (US$/kg)

Figure 35. United States Myostatin Market Share by Application in 2023 & 2030

Figure 36. United States Myostatin Sales in Value by Application (2019-2030) & (US$ Million)

Figure 37. United States Myostatin Sales Market Share in Value by Application (2019-2030)

Figure 38. United States Myostatin Sales by Application (2019-2030) & (kg)

Figure 39. United States Myostatin Sales Market Share in Volume by Application (2019-2030)

Figure 40. United States Myostatin Price by Application (2019-2030) & (US$/kg)

Figure 41. The Top 5 and 10 Largest Manufacturers of Myostatin in the World: Market Share by Myostatin Revenue in 2023

Figure 42. Global Myostatin Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 43. Global Myostatin Sales in Volume Market Share by Region (2019-2030)

Figure 44. Global Myostatin Sales in Value Market Share by Region (2019-2030)

Figure 45. Americas Myostatin Sales in Volume Growth Rate 2019-2030 (kg)

Figure 46. Americas Myostatin Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 47. Americas Myostatin Sales by Type (2019-2030) & (kg)

Figure 48. Americas Myostatin Sales Market Share in Volume by Type (2019-2030)

Figure 49. Americas Myostatin Sales by Application (2019-2030) & (kg)

Figure 50. Americas Myostatin Sales Market Share in Volume by Application (2019-2030)

Figure 51. United States Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 52. Canada Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 53. Mexico Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 54. Brazil Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 55. EMEA Myostatin Sales in Volume Growth Rate 2019-2030 (kg)

Figure 56. EMEA Myostatin Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 57. EMEA Myostatin Sales by Type (2019-2030) & (kg)

Figure 58. EMEA Myostatin Sales Market Share in Volume by Type (2019-2030)

Figure 59. EMEA Myostatin Sales by Application (2019-2030) & (kg)

Figure 60. EMEA Myostatin Sales Market Share in Volume by Application (2019-2030)

Figure 61. Europe Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 62. Middle East Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 63. Africa Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 64. China Myostatin Sales in Volume Growth Rate 2019-2030 (kg)

Figure 65. China Myostatin Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 66. China Myostatin Sales by Type (2019-2030) & (kg)

Figure 67. China Myostatin Sales Market Share in Volume by Type (2019-2030)

Figure 68. China Myostatin Sales by Application (2019-2030) & (kg)

Figure 69. China Myostatin Sales Market Share in Volume by Application (2019-2030)

Figure 70. APAC Myostatin Sales in Volume Growth Rate 2019-2030 (kg)

Figure 71. APAC Myostatin Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 72. APAC Myostatin Sales by Type (2019-2030) & (kg)

Figure 73. APAC Myostatin Sales Market Share in Volume by Type (2019-2030)

Figure 74. APAC Myostatin Sales by Application (2019-2030) & (kg)

Figure 75. APAC Myostatin Sales Market Share in Volume by Application (2019-2030)

Figure 76. Japan Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 77. South Korea Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 78. China Taiwan Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 79. Southeast Asia Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 80. India Myostatin Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 81. Myostatin Value Chain

Figure 82. Myostatin Production Process

Figure 83. Channels of Distribution (Direct Vs Distribution)

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Myostatin market? zhanKai

The top companies in the global Myostatin market are Bio-Techne、Prospec、NeoScientific.

Related Reports

Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Myostatin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 163
USD 4900.00
(Single User License)
Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Myostatin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
Myostatin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Myostatin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 126
USD 3950.00
(Single User License)
Global Myostatin Market Research Report 2026
The global Myostatin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 145
USD 2900.00
(Single User License)
Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Myostatin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 169
USD 4900.00
(Single User License)
Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Myostatin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 97
USD 4250.00
(Single User License)
Global Myostatin Market Research Report 2025
The global market for Myostatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 104
USD 2900.00
(Single User License)
Myostatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Myostatin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 116
USD 3950.00
(Single User License)
Global Myostatin Market Research Report 2024
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published Date: 2024-08-24
Pages: 104
USD 2900.00
(Single User License)
Global Myostatin Market Insights, Forecast to 2030
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published Date: 2024-08-24
Pages: 166
USD 4900.00
(Single User License)

Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Myostatin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 163
USD 4900.00 (Single User License)
Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Myostatin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
USD 4250.00 (Single User License)
Myostatin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Myostatin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 126
USD 3950.00 (Single User License)
Global Myostatin Market Research Report 2026
The global Myostatin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 145
USD 2900.00 (Single User License)
Global Myostatin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Myostatin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 169
USD 4900.00 (Single User License)
Global Myostatin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Myostatin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 97
USD 4250.00 (Single User License)
Global Myostatin Market Research Report 2025
The global market for Myostatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 104
USD 2900.00 (Single User License)
Myostatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Myostatin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 116
USD 3950.00 (Single User License)
Global Myostatin Market Research Report 2024
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published: 2024-08-24
Pages: 104
USD 2900.00 (Single User License)
Global Myostatin Market Insights, Forecast to 2030
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published: 2024-08-24
Pages: 166
USD 4900.00 (Single User License)